Longitudinal assessment demonstrates neurochemical recovery in post-COVID CFS/ME patients, suggesting persistent symptoms.
Motivation: Long-term post-COVID syndrome involves lasting symptoms including chronic-fatigue-syndrome or myalgic-encephalomyelitis(CFS/ME). We aim to investigate longitudinal changes in mitochondrial dysregulation and neurochemical abnormalities, which may be linked to the recovery of the post-COVID syndrome. Goal(s): We seek to evaluate longitudinal changes in post-COVID CFS/ME patients in relation to neurochemical markers of neuroinflammation, redox imbalance, and neuronal dysfunction. Approach: Ten-patients with post-COVID CFS/ME were scanned using proton MRS at two-time points targeting at posterior cingulate gyrus(PCG). Results: Overall neuronal activity recovered in patients with post-COVID CFS/ME as well as chronic fatigue scores, but the recovery did not reach the levels observed in other metabolic information. Impact: A longitudinal assessment of neurochemical metabolites in PCG reveals that while neuronal activity may recover, clinical symptoms of post-COVID fatigue can persist, potentially alongside markers of mitochondrial dysfunction that show no improvement over time.
No takes yet. Share an insight, caveat, or question.
Yoo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: